The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

More than 1% of U.S. children between the ages of 2 and 18 had “extremely severe obesity” in 2023 — a 250% increase from 2008 ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

A few days earlier, the FDA approved Zepbound, an obesity drug that is a bit cheaper and appears more potent than Wegovy.

The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss. By Benjamin Mueller One of the leading new obesity drugs, Wegovy ...

Clinical trial data suggest that Wegovy works better for treating obesity than other approved drugs. If the clinical evidence holds up in the real world and is durable over time, this may justify ...